347 related articles for article (PubMed ID: 22898389)
61. [Invasive aspergillosis in immunocompromised patients].
Kliasova GA; Petrova NA; Galstian GM; Gotman LN; Vishnevskaia ES; Sysoeva EP; Khoroshko ND; Mikhaĭlova EA; Parovichnikova EN; Isaev VG
Ter Arkh; 2003; 75(7):63-8. PubMed ID: 12934484
[TBL] [Abstract][Full Text] [Related]
62. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
63. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
64. Clinical Features and Survival Outcomes of Invasive Aspergillosis in Pediatric Patients at a Medical School in Thailand.
Anugulruengkitt S; Trinavarat P; Chantranuwat P; Sritippayawan S; Pancharoen C; Thanyawee P
J Med Assoc Thai; 2016 Feb; 99(2):150-8. PubMed ID: 27249894
[TBL] [Abstract][Full Text] [Related]
65. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
66. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
67. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
68. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.
Balajee SA; Kano R; Baddley JW; Moser SA; Marr KA; Alexander BD; Andes D; Kontoyiannis DP; Perrone G; Peterson S; Brandt ME; Pappas PG; Chiller T
J Clin Microbiol; 2009 Oct; 47(10):3138-41. PubMed ID: 19675215
[TBL] [Abstract][Full Text] [Related]
69. Factors associated with mortality in transplant patients with invasive aspergillosis.
Baddley JW; Andes DR; Marr KA; Kontoyiannis DP; Alexander BD; Kauffman CA; Oster RA; Anaissie EJ; Walsh TJ; Schuster MG; Wingard JR; Patterson TF; Ito JI; Williams OD; Chiller T; Pappas PG
Clin Infect Dis; 2010 Jun; 50(12):1559-67. PubMed ID: 20450350
[TBL] [Abstract][Full Text] [Related]
70. Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-
Stemler J; Többen C; Lass-Flörl C; Steinmann J; Ackermann K; Rath PM; Simon M; Cornely OA; Koehler P
J Fungi (Basel); 2023 Apr; 9(4):. PubMed ID: 37108955
[TBL] [Abstract][Full Text] [Related]
71. Nationwide Surveillance of Azole Resistance in Aspergillus Diseases.
Vermeulen E; Maertens J; De Bel A; Nulens E; Boelens J; Surmont I; Mertens A; Boel A; Lagrou K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4569-76. PubMed ID: 25987612
[TBL] [Abstract][Full Text] [Related]
72. Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review.
Bernardeschi C; Foulet F; Ingen-Housz-Oro S; Ortonne N; Sitbon K; Quereux G; Lortholary O; Chosidow O; Bretagne S;
Medicine (Baltimore); 2015 Jul; 94(26):e1018. PubMed ID: 26131805
[TBL] [Abstract][Full Text] [Related]
73. Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Yamamuro R; Kimura M; Asano-Mori Y; Abe M; Nakamura S; Umeyama T; Yamagoe S; Miyazaki Y; Ogura S; Sakoh T; Mitsuki T; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0163021. PubMed ID: 34780271
[TBL] [Abstract][Full Text] [Related]
74. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.
Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Cardoso T; Paiva JA; Blasco-Navalpotro M; De Laere E; Dimopoulos G; Rello J; Vogelaers D; Blot SI;
Crit Care; 2015 Jan; 19(1):7. PubMed ID: 25928694
[TBL] [Abstract][Full Text] [Related]
75. Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance® registry analysis.
Husain S; Silveira FP; Azie N; Franks B; Horn D
Med Mycol; 2017 Apr; 55(3):269-277. PubMed ID: 27703022
[TBL] [Abstract][Full Text] [Related]
76. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).
Lortholary O; Gangneux JP; Sitbon K; Lebeau B; de Monbrison F; Le Strat Y; Coignard B; Dromer F; Bretagne S;
Clin Microbiol Infect; 2011 Dec; 17(12):1882-9. PubMed ID: 21668573
[TBL] [Abstract][Full Text] [Related]
77. Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.
Assendorp EL; Gresnigt MS; Sprenkeler EGG; Meis JF; Dors N; van der Linden JWM; Henriet SSV
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1915-1922. PubMed ID: 30027379
[TBL] [Abstract][Full Text] [Related]
78. A case-control study of the risk factors for developing aspergillosis following cardiac transplant.
Cook JC; Cook A; Tran RH; Chang PP; Rodgers JE
Clin Transplant; 2018 Sep; 32(9):e13367. PubMed ID: 30074643
[TBL] [Abstract][Full Text] [Related]
79. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
[TBL] [Abstract][Full Text] [Related]
80. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.
Dotis J; Roilides E
Mycoses; 2011 Nov; 54(6):e686-96. PubMed ID: 21615532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
